Module 7

1

Health Policy Analysis: Hypertension as a Public Health Policy Issue

MPH503

October 4, 2026

Health Policy Analysis: Hypertension as a Public Health Policy Issue

Hypertension is a major public health problem in the United States because it increases the risk of stroke, heart disease, kidney disease, and premature death. Many adults with hypertension do not have their blood pressure under control, and the burden is not shared equally across populations (Saleh et al., 2026). Hypertension is therefore more than an individual medical problem. It is also a policy issue involving access to preventive care, insurance coverage, affordable treatment, health education, and the social conditions that affect whether people can receive and continue care. This analysis examines two Affordable Care Act (ACA) policies that can affect hypertension outcomes: preventive-services coverage and Medicaid expansion. Million Hearts 2027 is also discussed as a national initiative that shows how evidence-based hypertension care can be put into practice.

Problem Statement

Hypertension is often called a silent condition because people may have high blood pressure for years without noticeable symptoms. Uncontrolled hypertension can lead to serious and preventable health problems. Recent evidence continues to show high hypertension prevalence and important differences in diagnosis and control across racial and socioeconomic groups (Saleh et al., 2026).

The policy problem is the gap between the number of adults who have hypertension and the number who are diagnosed, treated, and controlled. High rates of uncontrolled hypertension among U.S. adults contribute to preventable illness and death. Public policy can help by improving screening, insurance coverage, access to treatment, follow-up care, medication adherence, and equitable blood pressure control.

Background

Hypertension is closely connected to cardiovascular disease, which makes prevention and long-term control important for population health. Social determinants of health also affect hypertension outcomes. Access to healthcare, income, education, neighborhood conditions, transportation, and healthcare quality can influence whether a person is screened, receives treatment, and can follow a treatment plan. Chaturvedi et al. (2024) found that social and economic disadvantage contributes to disparities in hypertension and cardiovascular outcomes.

Hypertension also creates significant healthcare costs. Costs may include office visits, laboratory testing, medications, emergency care, hospitalizations, and treatment for complications. Kumar et al. (2024) found substantial hypertension-associated healthcare spending among privately insured U.S. adults. Earlier identification and better long-term management may help prevent expensive complications.

There are also ethical concerns. Public health policy should support fair access to screening and treatment while respecting patient choice. A person may want to control their blood pressure but still face barriers such as no insurance, medication costs, limited transportation, difficulty finding primary care, or lack of a home blood pressure monitor. These barriers show why hypertension should not be treated only as a matter of personal responsibility.

Million Hearts 2027 provides an important practice framework for improving hypertension care. The initiative is co-led by CDC and CMS and promotes standardized treatment, team-based care, accurate blood pressure measurement, self-measured blood pressure monitoring, and quality improvement (Wall et al., 2023). These strategies support the policy goal of moving beyond screening toward long-term blood pressure control.

Landscape

Many stakeholders are involved in hypertension policy. Federal agencies such as CDC and CMS influence public health priorities, insurance programs, quality measures, and healthcare financing. State governments make important decisions about Medicaid eligibility and implementation. Healthcare professionals, including physicians, nurses, nurse practitioners, and pharmacists, are responsible for screening, diagnosis, treatment, education, and monitoring. These groups generally benefit from policies that improve prevention and control, but they may face workforce, reimbursement, technology, and workflow challenges.

Patients and communities are central stakeholders. They benefit from affordable preventive care, stable insurance, understandable health education, medication access, and home monitoring. However, insurance coverage alone does not remove every barrier. Transportation, provider shortages, health literacy, trust in healthcare, and the cost of medications or equipment can still affect care. Knoll et al. (2024) showed that practical barriers can interfere with successful home blood pressure monitoring.

Insurers and employers are also affected because they pay for preventive services, medications, monitoring, and complications of uncontrolled hypertension. Pharmaceutical and medical-device companies have economic interests in medications and blood pressure equipment. Politically, policymakers must balance population health needs with government spending, state and federal responsibilities, and different views about the role of government in healthcare. These competing interests can make hypertension policy difficult even when effective clinical strategies are known.

Options

The first policy option is the ACA preventive-services coverage requirement. Many health plans are required to cover recommended preventive services without patient cost sharing. Blood pressure screening is an important preventive service because hypertension can be found before a person develops serious complications. A major advantage of this policy is that it lowers a financial barrier to screening and encourages earlier detection. Earlier diagnosis can lead to treatment before hypertension causes more serious and expensive health problems.

The limitation is that coverage for screening does not guarantee long-term control. A patient may receive a blood pressure screening but still have difficulty obtaining follow-up appointments, medications, transportation, or a home monitor. The policy should be evaluated by looking at screening rates, new diagnoses, treatment initiation, follow-up, medication adherence, blood pressure control, and differences in outcomes across population groups.

The second policy option is the ACA Medicaid expansion provision. Medicaid expansion allows participating states to extend Medicaid eligibility to more adults with low incomes. This policy addresses hypertension by improving access to insurance and ongoing healthcare rather than focusing only on one screening visit. Research supports the importance of insurance coverage for hypertension care. A 2024 systematic review found that economic policies that expand insurance coverage were generally associated with better antihypertensive treatment and blood pressure control (Ferdinand et al., 2024). Research on community health centers has also found that Medicaid expansion and insurance stability can support hypertension detection, treatment, and control (Cole et al., 2023).

Medicaid expansion also has limitations. Eligibility and implementation vary by state, and gaining insurance does not automatically remove provider shortages, transportation problems, medication barriers, or other social conditions. In addition, expanding coverage requires public funding and can create political disagreement about costs and government responsibility. The policy can be evaluated through insurance rates, primary care use, hypertension diagnosis, medication access, follow-up, blood pressure control, avoidable hospital use, and differences across racial and socioeconomic groups.

Both policies address important parts of the problem. The preventive-services requirement helps people receive screening with fewer direct financial barriers, while Medicaid expansion can provide broader access to continuing care for eligible adults with low incomes. Hypertension control requires both early detection and sustained treatment. Million Hearts 2027 can complement these legal policies by giving healthcare systems evidence-based strategies for improving blood pressure control.

Recommendations

Of the two policy options, ACA Medicaid expansion is the stronger option for the specific problem of uncontrolled hypertension because long-term blood pressure control requires continuing access to care. Screening is important, but people who are diagnosed also need follow-up visits, medications, monitoring, and support. Evidence suggests that insurance expansion can improve hypertension treatment and blood pressure control for many underserved patients (Ferdinand et al., 2024).

The best approach would be to strengthen access to Medicaid coverage while using the ACA preventive-services requirement and Million Hearts strategies together. Healthcare systems should use standardized hypertension treatment protocols, team-based care, home blood pressure monitoring when appropriate, and reliable follow-up for people with uncontrolled hypertension. Education should be understandable and culturally appropriate, and communities facing racial, economic, rural, or healthcare-access disparities should receive special attention.

Outcomes should be measured carefully. Evaluation should include the percentage of adults screened, diagnosed, started on treatment, taking medications as directed, completing follow-up, using home monitoring when appropriate, and reaching blood pressure control. Results should also be examined by race and ethnicity, age, insurance status, income, and geographic location when possible. This would show whether the policy improves overall outcomes without increasing existing health disparities.

References

Chaturvedi, A., et al. (2024). Social determinants of health and disparities in hypertension and cardiovascular diseases. Hypertension, 81(3), 357–369. https://doi.org/10.1161/HYPERTENSIONAHA.123.21354

Cole, M. B., et al. (2023). Diabetes and hypertension prevention and control in community health centers: Impact of the Affordable Care Act. Current Diabetes Reports. https://pubmed.ncbi.nlm.nih.gov/37646147/

Ferdinand, K. C., et al. (2024). Association of economic policies with hypertension management and control: A systematic review. JAMA Health Forum. https://pubmed.ncbi.nlm.nih.gov/38334993/

Knoll, L., Elwell, J., Arcari-Couture, J., & Alexander, N. (2024). The standardization of home blood pressure monitoring in primary care: A quality improvement project. Journal of Ambulatory Care Management, 47(1), 14–21. https://doi.org/10.1097/JAC.0000000000000482

Kumar, A., He, S., Pollack, L. M., Lee, J. S., Imoisili, O., Wang, Y., Kompaniyets, L., Luo, F., & Jackson, S. L. (2024). Hypertension-associated expenditures among privately insured US adults in 2021. Hypertension, 81(11), 2318–2328. https://doi.org/10.1161/HYPERTENSIONAHA.124.23401

Saleh, O., Rehan, N., Mostafa, S., & Qayyum, R. (2026). Trends in hypertension prevalence and control in the United States over 25 years. The Journal of Clinical Hypertension, 28(2), e70216. https://doi.org/10.1111/jch.70216

Wall, H. K., Wright, J. S., Fleisher, L. A., & Sperling, L. S. (2023). Improving blood pressure control in the United States: At the heart of Million Hearts 2027. American Journal of Hypertension, 36(8), 462–465. https://doi.org/10.1093/ajh/hpad029